Advances in the molecular design of potential anticancer agents via targeting of human telomeric DNA

Area of Science:

• Biochemistry
• Genetics
• Pharmacology

Background:

• Telomeres protect chromosomal ends from degradation.
• Shortened telomeres can cause genomic instability and cancer.
• Telomerase maintains telomere length, potentially driving cancer progression.

Purpose of the Study:

• To explore telomere structure, function, and evolution in anticancer drug design.
• To review recent advances in telomere-targeted drug development.
• To discuss the advantages and disadvantages of current methods.

Main Methods:

• Focus on small molecule-induced stabilization of G-quadruplex structures.
• Investigating compounds that stabilize human telomeric DNA G-quadruplexes.
• Reviewing literature on telomere-targeted anticancer drug design.

Main Results:

• Telomerase inhibitors are a viable strategy for anticancer drug development.
• Stabilization of G-quadruplex structures can lead to telomerase inhibition.
• Several compounds demonstrate efficacy in stabilizing G-quadruplex forms.

Conclusions:

• Telomere-targeted drug design, particularly G-quadruplex stabilization, is a promising area for cancer therapy.
• Further research is needed to optimize methods and overcome challenges.
• Future prospects involve developing efficient telomerase inhibitors for novel anticancer drugs.